Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Thrombocytosis × pelcitoclax × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocytosis 1 Small Cell Lung Carcinoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Lymphoma, Non-Hodgkin 1

Interventions

ruxolitinib 3 venetoclax 1 sonidegib 1 pevonedistat 1 pelcitoclax 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04354727 2022-07-12

A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy

Ascentage Pharma Group Inc.

Phase 1/2 Withdrawn

Polycythemia Vera, Thrombocytosis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡